-
Potential molecular targets in chemopreventative action of celecoxib: a prote...
International audience -
Suicide gene therapy in cancer: where do we stand now?
International audience -
Dose escalation of low molecular weight heparin to manage recurrent venous th...
International audience -
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
International audience -
Comparison of distribution and activity of nanoparticles with short interferi...
International audience -
[Place of cancer among the risk factors in venous thromboembolism].
International audience -
Prokineticins in angiogenesis and cancer.
International audience -
MicroRNAs and other small silencing RNAs in cancer.
International audience -
Cardiac tamponade in medical patients: a 10-year follow-up survey.
International audience -
Systematic review: the Trousseau syndrome revisited: should we screen extensi...
International audience -
[Venous thromboembolism and cancer].
International audience -
Differential sensitization of cancer cells to doxorubicin by DHA: a role for ...
Polyunsaturated fatty acids have been reported to enhance the cytotoxic activity of several anticancer drugs. In the present study, we observed that doxorubicin... -
Clinical usefulness of D-dimer testing in cancer patients with suspected pulm...
International audience -
Influence of specific alternative diagnoses on the probability of pulmonary e...
International audience -
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane f...
International audience -
Estimation of a potentially preventable fraction of venous thromboembolism: a...
International audience -
[Incidence and risk factors for venous thromboembolism].
International audience -
Should we screen patients with unprovoked venous thromboembolism for occult c...
International audience -
Cisplatin cytotoxicity: DNA and plasma membrane targets.
International audience -
Multi-observation PET image analysis for patient follow-up quantitation and t...
International audience
